# OnCo record paper-javelin-merkel-200-j-immunother-cancer-2018-update (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-javelin-merkel-200-j-immunother-cancer-2018-update/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-javelin-merkel-200-j-immunother-cancer-2018-update" ;
  schema:name "Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial"@en ;
  schema:description "Later report from the JAVELIN Merkel 200 trial registered as NCT02155647, in Journal for ImmunoTherapy of Cancer (2018); its title describes an updated or longer-term analysis."@en ;
  schema:url <https://onco.cc/key-papers/paper-javelin-merkel-200-j-immunother-cancer-2018-update/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1186/s40425-017-0310-x>, <https://pubmed.ncbi.nlm.nih.gov/29347993/>, <https://europepmc.org/article/MED/29347993>, <https://clinicaltrials.gov/study/NCT02155647> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1186/s40425-017-0310-x> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Kaufman HL, Russell JS, Hamid O, et al." ;
  onco:trials <https://onco.cc/trials/javelin-merkel-200/> ;
  onco:journals <https://onco.cc/journals/jitc/> .